Ruiz de Galarreta, Marina
51  results:
Search for persons X
?
3

NASH limits anti-tumour surveillance in immunotherapy-treat..:

Pfister, Dominik ; Núñez, Nicolás Gonzalo ; Pinyol, Roser...
info:eu-repo/semantics/altIdentifier/doi/10.1038/s41586-021-03362-0.  , 2021
 
?
6

NASH limits anti-tumour surveillance in immunotherapy-treat..:

Pfister, Dominik ; Núñez, Nicolás Gonzalo ; Pinyol, Roser...
info:eu-repo/semantics/altIdentifier/doi/10.1038/s41586-021-03362-0.  , 2021
 
?
8

Transcriptomic characterization of cancer-testis antigens i..:

Craig, Amanda J ; Garcia-Lezana, Teresa ; Ruiz de Galarreta, Marina...
Reproducció del document publicat a: https://doi.org/10.1371/journal.pgen.1009589.  , 2021
 
?
9

NASH limits anti-tumour surveillance in immunotherapy-treat..:

Pfister, Dominik ; Núñez, Nicolás Gonzalo ; Pinyol, Roser...
info:eu-repo/semantics/altIdentifier/doi/10.1038/s41586-021-03362-0.  , 2021
 
?
11

NASH limits anti-tumour surveillance in immunotherapy-treat..:

Pfister, Dominik ; Núñez, Nicolás Gonzalo ; Pinyol, Roser...
info:eu-repo/semantics/altIdentifier/doi/10.1038/s41586-021-03362-0.  , 2021
 
?
 
?
 
?
14

Cell type-specific pharmacological kinase inhibition for ca..:

Deshmukh, Manjeet ; Nakagawa, Shigeki ; Higashi, Takaaki...
https://research.rug.nl/en/publications/435d22fa-f1da-455f-bed7-3485b02f728b.  , 2018
 
?
15

Palbociclib (PD-0332991), a selective CDK4/6 inhibitor, res..:

Bollard, Julien ; Miguela, Verónica ; Ruiz de Galarreta, Marina...
info:eu-repo/semantics/altIdentifier/doi/10.1136/gutjnl-2016-312268.  , 2016
 
1-15